KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $11.1 billion.

  • Boston Scientific's Non-Current Debt rose 2418.6% to $11.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.1 billion, marking a year-over-year increase of 2418.6%. This contributed to the annual value of $11.1 billion for FY2025, which is 2418.6% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Non-Current Debt is $11.1 billion, which was up 2418.6% from $11.1 billion recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Non-Current Debt ranged from a high of $11.1 billion in Q4 2025 and a low of $8.4 billion during Q3 2023
  • Over the past 5 years, Boston Scientific's median Non-Current Debt value was $8.9 billion (recorded in 2022), while the average stood at $9.3 billion.
  • As far as peak fluctuations go, Boston Scientific's Non-Current Debt plummeted by 630.86% in 2023, and later skyrocketed by 2418.6% in 2025.
  • Quarter analysis of 5 years shows Boston Scientific's Non-Current Debt stood at $8.8 billion in 2021, then grew by 1.26% to $8.9 billion in 2022, then dropped by 3.86% to $8.6 billion in 2023, then rose by 4.63% to $9.0 billion in 2024, then rose by 24.19% to $11.1 billion in 2025.
  • Its last three reported values are $11.1 billion in Q4 2025, $11.1 billion for Q3 2025, and $11.1 billion during Q2 2025.